Journal of Pharmaceutical Analysis · 2023 · 16 citations · 35 references
Life SciencesBiochemistryPharmacologyCellular MetabolismInflammationMetabolismCitric Acid CycleEnergy MetabolismGlycolysis RegulationMetabolic Pathway AnalysisMetabolic ReprogrammingTricarboxylic Acid CycleAnti-inflammatory ActivityAnti-inflammatory MechanismsCellular Metabolic ReprogrammingMetabolic ModulationTca Cycle Flux ControlTca Cycle InhibitionTricarboxylic Acid Cycle FluxTricarboxylic Acid Cycle Metabolism
Evidence indicates that metabolic reprogramming characterized by the changes in cellular metabolic patterns contributes to the pathogenesis of pulmonary fibrosis (PF). It is considered as a promising therapeutic target anti-PF. The well-documented against PF properties of Tanshinone IIA (Tan IIA) have been primarily attributed to its antioxidant and anti-inflammatory potency. Emerging evidence suggests that Tan IIA may target energy metabolism pathways, including glycolysis and tricarboxylic acid (TCA) cycle. However, the detailed and advanced mechanisms underlying the anti-PF activities remain obscure. In this study, we applied [U-13C]-glucose metabolic flux analysis (MFA) to examine metabolism flux disruption and modulation nodes of Tan IIA in PF. We identified that Tan IIA inhibited the glycolysis and TCA flux, thereby suppressing the production of TGF-β1- dependent extracellular matrix and the differentiation and proliferation of myofibroblasts in vitro. We further revealed that Tan IIA inhibited the expression of key metabolic enzyme hexokinase 2 (HK2) by inhibiting phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR)/hypoxia-inducible factor 1α (HIF-1α) pathway activities, which decreased the accumulation of abnormal metabolites. Notably, we demonstrated that Tan IIA inhibited ATP citrate lyase (ACLY) activity, which reduced the collagen synthesis pathway caused by cytosol citrate consumption. Further, these results were validated in a mouse model of bleomycin-induced PF. This study was novel in exploring the mechanism of the occurrence and development of Tan ⅡA in treating PF using 13C-MFA technology. It provided a novel understanding of the mechanism of Tan IIA against PF from the perspective of metabolic reprogramming.
35
ATP citrate lyase inhibition can suppress tumor cell growth
Georgia Hatzivassiliou, Fangping Zhao, Daniel E. Bauer et al. · Cancer Cell · 2005 · 1.1K citations · Full text
13C-based metabolic flux analysis
Nicola Zamboni, Sarah‐Maria Fendt, Martin Rühl et al. · Nature Protocols · 2009 · 561 citations · Full text
Macrophage-Associated PGK1 Phosphorylation Promotes Aerobic Glycolysis and Tumorigenesis
Yajuan Zhang, Guanzhen Yu, Huiying Chu et al. · Molecular Cell · 2018 · 394 citations · Full text